Search

Your search keyword '"ROCCA M"' showing total 288 results

Search Constraints

Start Over You searched for: Author "ROCCA M" Remove constraint Author: "ROCCA M" Topic multiple sclerosis Remove constraint Topic: multiple sclerosis
288 results on '"ROCCA M"'

Search Results

1. Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study.

2. Prognosis of a second clinical event from baseline MRI in patients with a CIS: a multicenter study using a machine learning approach.

3. Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients.

5. Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and magnetic resonance imaging study.

6. Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.

7. Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients.

8. The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS.

9. Functional MRI in investigating cognitive impairment in multiple sclerosis.

10. Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis.

11. Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.

12. Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis.

13. Future MRI tools in multiple sclerosis.

15. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.

16. Contribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis.

17. Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.

18. Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.

19. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--no.

20. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.

21. Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study.

22. Abnormalities of resting state functional connectivity are related to sustained attention deficits in MS.

23. Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.

24. A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.

25. Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years.

27. Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue.

28. Cortical lesions in children with multiple sclerosis.

29. Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.

30. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

31. The contribution of MRI in assessing cognitive impairment in multiple sclerosis.

32. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

33. MRI and cognition in multiple sclerosis.

34. Neuropsychological rehabilitation in adult multiple sclerosis.

35. Safety and efficacy of natalizumab in children with multiple sclerosis.

36. MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

38. Preserved brain adaptive properties in patients with benign multiple sclerosis.

39. A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients.

40. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.

41. A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.

42. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.

43. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis.

44. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.

45. Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis.

46. Functional MR imaging in multiple sclerosis.

47. Reproducibility of fMRI in the clinical setting: implications for trial designs.

48. Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition.

49. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.

50. Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.

Catalog

Books, media, physical & digital resources